Wu Mengchao, male, Han nationality, is a world-famous Chinese hepatobiliary surgery scientist and surgeon, who is currently an acadamecian at the Chinese Academy of Sciences. He is generally ...

Diagnosis of hepatobiliary neoplasms often occurs late in the disease process owing to the insidious and often asymptomatic early course of disease. Current biomarkers for hepatocellular carcinoma ...

Hepatic arterial infusion chemotherapy plus lenvatinib and PD-1 inhibitors as first-line treatment for hepatocellular carcinoma with high tumor burden and portal vein tumor thrombus. This is an ASCO ...

Any condition that affects the hepatobiliary system's ability to operate is typically referred to as hepatobiliary illness. The disease can affect everyone, from superficial infections or scars to ...

The University of Alabama at Birmingham (UAB) Liver Transplant faculty have busy elective hepatobiliary practices. Over 150 major liver resections or extrahepatic biliary tree procedures are performed ...

Objective There is limited prospective evidence on the association of physical activity with hepatobiliary cancer subtypes and other major hepatobiliary diseases, especially in China. We aimed to ...

CA: Carbohydrate antigen; CT: Computed tomography; DIA: Digital imaging analysis; NPV: Negative predictive value; PPV: Positive predictive value; US: Ultrasound ...

File photo shows Wu Mengchao, then 96, on a TV program on May 26, 2018. China's top hepatobiliary surgeon Wu Mengchao, known as the "father of Chinese hepatobiliary surgery," passed away at 99 on ...

Correlations of estrogen receptor (ER) related genomic transcription and ER gene expression with increasing AJCC stage of ER-positive breast cancer ...